Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]
Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]
A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum [Yahoo! Finance]
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™